HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,873-7,884 of 27,277
Device study icon
CompletedNCT06215963

A4i-O: A Platform for Complex Behavioral Health to Address OUD

Official study title

App for Independence-O (A4i-O) - Expanding a Validated Platform for Complex Behavioral Health to Address Opioid Use Disorder

This study has finished and is no longer accepting participants.

In Toronto
AddictionDevice studyAges 18+
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Behavioral study icon
CompletedNCT05120856

AAT-App Outpatient study

Official study title

AAT-App Trial: A Clinical Trial of a "Brain-training" Smartphone App to Help Reduce Alcohol Use in People Accessing Outpatient Alcohol Treatment

This study has finished and is no longer accepting participants.

Multiple locations, including Coburg
AddictionBehavioural studyAges 18+
Countries
Australia
Sponsor
Turning Point
Behavioral study icon
TerminatedACTRN12622001245785

AAT-App Rehabilitation study: The effect of smartphone-delivered cognitive training on relapse and treatment re-admission among patients leaving residential alcohol treatment.

Official study title

The AAT-App Rehabilitation trial: A randomised controlled trial testing the effect of a novel cognitive bias modification smartphone application on alcohol use and craving among clients exiting rehabilitation treatment for alcohol use disorder.

This study ended early.

Multiple locations, including Richmond
AddictionInterventional studyAges 18+
Countries
Australia
Sponsor
Monash University
Behavioral study icon
CompletedNCT04923256

AAT-APP+: A Novel Brain-training App to Reduce Drinking

Official study title

AAT-APP+: A Pilot RCT of a Novel Smart-phone App to Reduce Alcohol Consumption Among Middle to Older Adults in the Eastern Health Community

This study has finished and is no longer accepting participants.

In Richmond
AddictionBehavioural studyAges 55+
Countries
Australia
Sponsor
Turning Point
Drug study icon
CompletedNCT04895215

AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

Official study title

A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of AB-2004 in an Autism Spectrum Disorder Population

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
AnxietyMedication studyAges 5–17
Countries
United States, Australia, New Zealand
Sponsor
Vertero Therapeutics
Other study type icon
Active Not RecruitingNCT06336538

Abbreviated MBCT for Depression in Older Black or African American Breast Cancer Survivors

Official study title

Community Engagement in the Development of an Abbreviated Mindfulness-Based Cognitive Therapy Intervention for Depression in Older African American/Black Breast Cancer Survivors (Community Minds)

This study is no longer accepting new participants.

In Cleveland
DepressionInterventional studyAges 65+
Countries
United States
Sponsor
Case Comprehensive Cancer Center
Behavioral study icon
CompletedNCT06957925

ABC School Intervention Among Ugandan Adolescents

Official study title

A Cultural-sensitive Act-Belong-Commit-based School Intervention Reduces the Burden of Anxiety and Depression in Adolescents: a Pilot Cluster-randomized Trial From Uganda

This study has finished and is no longer accepting participants.

Multiple locations, including Gulu
Anxiety, DepressionBehavioural studyAges 14–17
Countries
Uganda
Sponsor
KU Leuven
Drug study icon
CompletedNCT00545675

Aripiprazole added to divalproex for 24-week bipolarity treatment

About this title

Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness

Read the official source — NCT00545675
Official study title

Multi-center, Double-blind, Randomized, Comparative Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify and Depakote in 24-week Treatment of Mania in Patients With Bipolar Disorder Remitted After 6-week Treatment With Abilify and Depakote

This study has finished and is no longer accepting participants.

In Seoul
BipolarityMedication studyAges 18–65
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Drug study icon
CompletedNCT00545142

Aripiprazole added to divalproex for acute mania in bipolarity

About this title

Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness

Read the official source — NCT00545142
Official study title

Multi-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder

This study has finished and is no longer accepting participants.

In Seoul
BipolarityMedication studyAges 18–65
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.